Ibrutinib, rituximab and venetoclax in the treatment of patients with newly diagnosed MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:21 2 years ago 214 Скачать Далее
Acalabrutinib plus venetoclax and rituximab in MCL & the importance of chemotherapy-free regimens VJHemOnc – Video Journal of Hematology & HemOnc 3:42 1 year ago 269 Скачать Далее
Acalabrutinib plus venetoclax and rituximab in the treatment of MCL VJHemOnc – Video Journal of Hematology & HemOnc 0:26 2 years ago 128 Скачать Далее
OAsIs trial update: ibrutinib, venetoclax plus obinutuzumab in newly diagnosed MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:30 4 years ago 195 Скачать Далее
Acalabrutinib and rituximab as first-line therapy for older patients with MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:50 1 year ago 447 Скачать Далее
Addition of venetoclax to lenalidomide and rituximab in patients with untreated MCL VJHemOnc – Video Journal of Hematology & HemOnc 2:00 1 year ago 133 Скачать Далее
SYMPATICO: safety and efficacy of ibrutinib plus venetoclax for R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 3:18 3 years ago 87 Скачать Далее
TrAVeRse: acalabrutinib + venetoclax and rituximab for treatment-naïve MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:12 6 months ago 141 Скачать Далее
Chemotherapy-free treatment for MCL: success from the WINDOW-2 trial VJHemOnc – Video Journal of Hematology & HemOnc 1:39 1 year ago 445 Скачать Далее
Venetoclax, lenalidomide and rituximab in R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 2:22 3 years ago 66 Скачать Далее
Ibrutinib improves PFS by 50% for older patients with newly diagnosed mantle cell lymphoma ecancer 6:32 2 years ago 127 Скачать Далее
Venetoclax and R2 in mantle cell lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 5:50 3 years ago 412 Скачать Далее
Venetoclax, lenalidomide + rituximab: a chemotherapy-free regimen for previously untreated MCL VJHemOnc – Video Journal of Hematology & HemOnc 2:50 1 year ago 246 Скачать Далее
The role of venetoclax in R/R MCL & options for patients who progress on venetoclax VJHemOnc – Video Journal of Hematology & HemOnc 2:06 1 year ago 123 Скачать Далее
Phase II trial of acalabrutinib, lenalidomide and rituximab in patients with MCL VJHemOnc – Video Journal of Hematology & HemOnc 5:12 1 year ago 128 Скачать Далее
Does upfront treatment with venetoclax, lenalidomide, and rituximab enhance tumor responses in MCL? Lymphoma Hub 2:35 3 years ago 109 Скачать Далее
Venetoclax Resistance: Mechanisms and Treatment Options HMP Education 20:43 4 years ago 2 866 Скачать Далее
Acalabrutinib in combination with bendamustine & rituximab in treatment-naïve or R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:31 1 year ago 249 Скачать Далее
Optimizing treatment of MCL VJHemOnc – Video Journal of Hematology & HemOnc 2:31 3 years ago 158 Скачать Далее
PHILEMON trial: ibrutinib, lenalidomide and rituximab in R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:46 3 years ago 79 Скачать Далее
